You just read:

PharmaEngine Announces Filing New Drug Application (NDA) of MM-398 (PEP02) to Taiwan FDA as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer

News provided by

PharmaEngine, Inc.

May 31, 2015, 11:20 ET